Welcome to our dedicated page for MESO NUMISMATICS news (Ticker: MSSV), a resource for investors and traders seeking the latest updates and insights on MESO NUMISMATICS stock.
Meso Numismatics, Inc. (MSSV), a leading company in the field of regenerative medicine, has demonstrated remarkable growth and innovation in recent years. The company specializes in the development, commercialization, and distribution of stem cell therapies and regenerative medical solutions through its wholly-owned subsidiary, Global Stem Cells Group.
The company's operations are diverse and encompass several key areas:
- Training: Meso Numismatics offers certified training courses for physicians, equipping them with the latest knowledge and skills in stem cell therapies. The company is internationally recognized as an expert in stem cell and regenerative medicine.
- Product Sales: The company engages in the manufacturing and sale of state-of-the-art technology, supplies, and equipment related to stem cell applications, catering to medical professionals' needs.
- Equipment Sales: Meso Numismatics produces cutting-edge technology and supplies for regenerative medicine, ensuring high-quality products are available to practitioners.
- Patient Procedures: The company operates clinics in Cancun and is expanding into Dubai and Istanbul, providing standardized regenerative medical treatments for various health issues such as autoimmune diseases, neurodegenerative conditions, and aesthetics.
In its latest achievements, Meso Numismatics closed its 2023 fiscal year with approximately $2.4 million in sales, marking a more than 50% increase over 2022. The company expects to reach $5 million in revenues and approximately $1 million in operating profits for the fiscal year 2024. A significant portion of this growth is anticipated to come from the patient procedure category as the Cancun clinic, which is finalizing its full build-out, increases its capacity.
The Cancun clinic offers a wide range of procedures, including hormone replacement, autoimmune treatments, neurodegenerative therapies, osteoarthritis, cardiovascular treatments, aesthetic/anti-aging procedures, hair transplants, sports medicine, spinal cord injury treatments, MS, and autism therapies. The Dubai clinic is expected to be fully operational by the end of the second quarter of 2024, further expanding the company's reach.
Moreover, Meso Numismatics is actively collaborating with leading research institutions, universities, and industry experts to accelerate the development and commercialization of regenerative medical solutions. These partnerships foster a collaborative ecosystem that ensures the company remains at the forefront of innovation.
With a global vision, Meso Numismatics is dedicated to making a positive impact on healthcare worldwide. The company is exploring opportunities to expand its reach and make its cutting-edge medical procedures accessible to patients across borders. Currently, 26 clinics in 21 countries carry the company's banner, showcasing its global presence.
In a recent announcement, the company stated it would undergo a name change to Regenerative Medical Technology Group Inc., reflecting its core business better. Additionally, it will reduce its authorized shares outstanding from 6.5 billion to 100 million shares.
For more information on Meso Numismatics and Global Stem Cells Group, please visit www.stemcellsgroup.com.
Meso Numismatics (MSSV), soon to be renamed Regenerative Medical Technology Group, announces Global Stem Cells Group's (GSCG) sponsorship of three major Regenerative Medicine events in Peru this September. These events include:
1. International Regenerative Medicine Conference by ISSCA (Sept 6-7)
2. AMDAL 2024 (Sept 14-15)
3. MDE24 International Congress of Medicine and Aesthetic Dermatology (Sept 20-21)
Cellgenic, a division of GSCG, will showcase its new line of peptides and advanced exosome products at these events. The company aims to introduce its pioneering exosome technology to medical professionals, highlighting the potential growth in the Latin American market for exosome-based treatments.
Meso Numismatics (MSSV), a leader in regenerative medicine, announces the launch of a new peptide line by its division Global Stem Cells Group (GSCG). The Cellgenic peptide line aims to enhance stem cell applications and improve patient outcomes in regenerative medicine. The new line includes peptides for:
- Healing and recovery (BPC157, TB500)
- Anti-aging and skin health (GHK-CU, Epithalon)
- Metabolic function and longevity (MOTS-C, SS31)
- Aesthetic and sexual health (Melanotan 2)
- Growth hormone and body composition (Ipamorelin, Tesamorelin)
- Weight management and diabetes (Semaglutide, Tirzepatide)
This launch underscores GSCG's commitment to innovation and its position as a global leader in regenerative medicine.
Meso Numismatics, Inc. (MSSV) has partnered with STEM LIFE clinic in Mexico City to enhance regenerative medicine services. This collaboration aims to establish high-quality stem cell therapies in Mexico, backed by an affiliation from the International Society for the Application of Stem Cells (ISSCA). The new center will feature an autologous tissue processing lab and an allogeneic tissue bank, enhancing access to stem cell treatments. CEO Benito Novas stated that GSCG is rapidly expanding to meet market demand in regenerative medicine.
Meso Numismatics (MSSV) has announced the opening of new stem cell therapy and regenerative medicine facilities in Indonesia, partnering with Dr. Yanti Aesthetic Clinics. This expansion is part of Global Stem Cells Group's strategy to address the growing demand for regenerative therapies in populous areas. The collaboration aims to create centers of excellence in cell therapy, leveraging local expertise to enhance service standards. CEO David Christensen highlighted aspirations to significantly impact the regenerative medicine sector and expand further into Asian markets.
Meso Numismatics (MSSV) announces a significant partnership through its subsidiary, Global Stem Cells Group (GSCG), with the Ramzan Ali Stem Cell Center in Pakistan. This exclusive 5-year contract aims to enhance regenerative medicine services in the country. GSCG plans to establish centers of excellence in cell therapy, provide physician training, and launch its CELLGENIC line of cellular products. The initiative aligns with GSCG's strategy to expand its global presence in the lucrative health industry. The collaboration is expected to enhance patient access to state-of-the-art stem cell therapies.
Meso Numismatics (MSSV) has successfully closed its acquisition of Global Stem Cells Group, positioning itself in the expanding Regenerative Medicine sector. This acquisition grants MSSV access to Global's extensive network of 29 offices across 25 countries and its advanced stem cell technologies. The Regenerative Medicine market is projected to grow at double-digit rates over the next decade. Additionally, MSSV has restructured its $10.5M financing agreement, extending the warrant maturity period to seven years and instating a two-year lock-up on warrant exercises.
Meso Numismatics (MSSV) announced the signing of a Final Definitive Agreement with Global Stem Cells Group (GSCG) to expand into the stem cell industry. CEO Dave Christensen expressed enthusiasm about the partnership and its potential for growth in this sector. This announcement is part of Meso's strategy to leverage technology and expertise in numismatics within the Meso Region, including Central America and the Caribbean. The company aims to enhance its market presence and inventory offerings.
Meso Numismatics (MSSV) announces a 90-day extension of its Letter of Intent (LOI) with Global Stem Cells Group, targeting a transaction closure by June 23, 2021. The company is current with SEC filings and is finalizing its audited 2020 annual 10K filing. This extension is deemed the final phase before the deal closes, signaling Meso's entry into the expanding stem cell market. The company emphasizes its commitment to enhancing its business in the Meso Region, including Central America and the Caribbean.
FAQ
What is the current stock price of MESO NUMISMATICS (MSSV)?
What is the market cap of MESO NUMISMATICS (MSSV)?
What is Meso Numismatics, Inc.?
What are the main areas of business for Meso Numismatics?
What recent achievements has Meso Numismatics made?
Where are Meso Numismatics' clinics located?
What procedures are offered at Meso Numismatics' clinics?
What is the company's growth strategy?
What is the significance of the company's name change?
How many clinics does Meso Numismatics operate globally?
What are the financial expectations for Meso Numismatics in 2024?
Where can I find more information about Meso Numismatics?
